These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9404972)

  • 21. Use of Rotational Thromboelastometry in Liver Transplantation Is Associated With Reduced Transfusion Requirements.
    Schumacher C; Eismann H; Sieg L; Friedrich L; Scheinichen D; Vondran FWR; Johanning K
    Exp Clin Transplant; 2019 Apr; 17(2):222-230. PubMed ID: 30295585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An assessment of thromboelastometry to monitor blood coagulation and guide transfusion support in liver transplantation.
    Blasi A; Beltran J; Pereira A; Martinez-Palli G; Torrents A; Balust J; Zavala E; Taura P; Garcia-Valdecasas JC
    Transfusion; 2012 Sep; 52(9):1989-98. PubMed ID: 22304465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of two thrombokinetic measurements (thrombelastograph and Sonoclot) during liver transplantation.
    Goldman E; Yablok D; Tesi RJ; Elkhammas E; Henry M; Ferguson R
    Transplant Proc; 1993 Apr; 25(2):1820. PubMed ID: 8470179
    [No Abstract]   [Full Text] [Related]  

  • 24. Factor XIII activity during orthotopic liver transplantation.
    Himmelreich G; Müller C; Isenberg C; Bechstein WO; Roissant R; Riess H
    Semin Thromb Hemost; 1993; 19(3):243-5. PubMed ID: 7689750
    [No Abstract]   [Full Text] [Related]  

  • 25. Coagulation defects do not predict blood product requirements during liver transplantation.
    Massicotte L; Beaulieu D; Thibeault L; Roy JD; Marleau D; Lapointe R; Roy A
    Transplantation; 2008 Apr; 85(7):956-62. PubMed ID: 18408574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From plasma transfusion to individualized, goal-directed coagulation factor administration.
    Spahn DR
    J Cardiothorac Vasc Anesth; 2013 Aug; 27(4 Suppl):S16-9. PubMed ID: 23910532
    [No Abstract]   [Full Text] [Related]  

  • 27. Methods for monitoring hemostasis during and following cardiac surgery.
    Huffman SM; Stammers AH
    Int Anesthesiol Clin; 1996; 34(2):123-39. PubMed ID: 8799750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of aprotinin on coagulation parameters in liver transplantation.
    Welte M; Groh J; Azad S; Anthuber M; Haller M; Kratzer MA
    Semin Thromb Hemost; 1993; 19(3):297-9. PubMed ID: 7689755
    [No Abstract]   [Full Text] [Related]  

  • 29. [The thromboelastometric criteria of hemostasis disorders correction during liver transplantation].
    Minov AF; Dziadz'ko AM; Rummo OO
    Anesteziol Reanimatol; 2012; (2):35-41. PubMed ID: 22834286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Coagulation Profile of End-Stage Liver Disease and Considerations for Intraoperative Management.
    Forkin KT; Colquhoun DA; Nemergut EC; Huffmyer JL
    Anesth Analg; 2018 Jan; 126(1):46-61. PubMed ID: 28795966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood usage in a newly organized liver transplant program.
    Kindscher J
    Transplant Proc; 1993 Apr; 25(2):1823. PubMed ID: 8470181
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical use of synthetic antifibrinolytic agents during liver transplantation.
    Kang Y
    Semin Thromb Hemost; 1993; 19(3):258-61. PubMed ID: 8362255
    [No Abstract]   [Full Text] [Related]  

  • 33. Should abnormal coagulation data found in thromboelastography be corrected during liver transplantation? Experience of two cases.
    Wang CH; Cheng KW; Chen CL; Wu SC; Shih TS; Jawan B; Huang CJ
    Acta Anaesthesiol Taiwan; 2014 Mar; 52(1):43-5. PubMed ID: 24999219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coagulation monitoring in the perioperative period.
    Spiess BD
    Acta Anaesthesiol Scand Suppl; 1996; 109():77-9. PubMed ID: 8901955
    [No Abstract]   [Full Text] [Related]  

  • 35. Viscoelastic Monitoring in Liver Transplantation.
    Malleeswaran S; Sivajothi S; Reddy MS
    Liver Transpl; 2022 Jun; 28(6):1090-1102. PubMed ID: 34724319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in urokinase-type plasminogen activator in orthotopic liver transplantation.
    Himmelreich G; Dooijewaard G; Breinl P; Bechstein WO; Blumhardt G; Kluft C; Riess H
    Semin Thromb Hemost; 1993; 19(3):311-4. PubMed ID: 7689759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transfusion triggers in orthotopic liver transplantation: a comparison of the thromboelastometry analyzer, the thromboelastogram, and conventional coagulation tests.
    Coakley M; Reddy K; Mackie I; Mallett S
    J Cardiothorac Vasc Anesth; 2006 Aug; 20(4):548-53. PubMed ID: 16884987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between rotation thrombelastometry ROTEM analysis and standard haemostatic parameters during liver transplantation.
    Stancheva A; Spassov L; Tzatchev K
    Clin Lab; 2011; 57(5-6):407-13. PubMed ID: 21755833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aprotinin in orthotopic liver transplantation.
    Bechstein WO; Riess H; Blumhardt G; Himmelreich G; Jochum M; Gerlach H; Rossaint R; Keck H; Neuhaus P
    Semin Thromb Hemost; 1993; 19(3):262-7. PubMed ID: 7689751
    [No Abstract]   [Full Text] [Related]  

  • 40. Point-of-Care Testing in Liver Disease and Liver Surgery.
    Abeysundara L; Mallett SV; Clevenger B
    Semin Thromb Hemost; 2017 Jun; 43(4):407-415. PubMed ID: 28359132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.